GB1178982A - Anthelmintic Compositions - Google Patents
Anthelmintic CompositionsInfo
- Publication number
- GB1178982A GB1178982A GB08881/66A GB1888166A GB1178982A GB 1178982 A GB1178982 A GB 1178982A GB 08881/66 A GB08881/66 A GB 08881/66A GB 1888166 A GB1888166 A GB 1888166A GB 1178982 A GB1178982 A GB 1178982A
- Authority
- GB
- United Kingdom
- Prior art keywords
- anthelmintic compositions
- thienyl
- phenyl
- alkyl
- radical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,178,982. Anthelmintic compositions. MERCK & CO. Inc. 21 June, 1967 [29 April, 1966], No. 18881/66. Heading A5B. Anthelmintic compositions comprise piperazine carbodithioic acid (the complex resulting from the reaction of equimolar amounts of piperazine and CS 2 ), and a benzimidazole of the general formula: wherein R is a mono- or bi-cyclic carbocyclic aryl radical, e.g. phenyl or naphthyl, an orthohaloaryl radical, a heteroaromatic radical containing 1 to 3 heteroatoms which are N, S or O, (e.g. furyl, thienyl, pyrryl, pyridyl, coumarinyl, thiacoumarinyl, thiazolyl, isothiazolyl and thiadiazolyl), R 5 and R 6 are H, C 1-5 alkyl, C 1-5 alkoxy, C 1-5 alkylthio, phenoxy, phenylthio, halo, phenyl, halophenyl or thienyl, only one of R 5 and R 6 being other than H, and R 2 is H, C 1-5 alkyl, C 1-5 alkanoyl or benzoyl. They may be in conventional solid and liquid forms for oral administration to animals, including enteric preparations and mixed with animal feeds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08881/66A GB1178982A (en) | 1966-04-29 | 1966-04-29 | Anthelmintic Compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08881/66A GB1178982A (en) | 1966-04-29 | 1966-04-29 | Anthelmintic Compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1178982A true GB1178982A (en) | 1970-01-28 |
Family
ID=10120035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08881/66A Expired GB1178982A (en) | 1966-04-29 | 1966-04-29 | Anthelmintic Compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1178982A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999055171A1 (en) * | 1998-04-24 | 1999-11-04 | Künzle Farma Ag | Licking stone |
EP1303309A1 (en) * | 2000-05-23 | 2003-04-23 | Commonwealth Scientific And Industrial Research Organisation | Rapidly-disintegrating tablets for animals |
-
1966
- 1966-04-29 GB GB08881/66A patent/GB1178982A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999055171A1 (en) * | 1998-04-24 | 1999-11-04 | Künzle Farma Ag | Licking stone |
EP1303309A1 (en) * | 2000-05-23 | 2003-04-23 | Commonwealth Scientific And Industrial Research Organisation | Rapidly-disintegrating tablets for animals |
EP1303309A4 (en) * | 2000-05-23 | 2004-01-28 | Commw Scient Ind Res Org | Rapidly-disintegrating tablets for animals |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1409693A (en) | Triazolobenzodiazepines | |
GB1374823A (en) | Triazolylbenzophenones | |
ES8201549A1 (en) | 3,4,5-trihydroxypiperidine derivatives, process for their preparation, their use as medicines and in animal feeding. | |
GB1271466A (en) | Thiocarbamic acid derivatives | |
GB1323502A (en) | Erythromycin derivatives | |
GB1324318A (en) | Triazolobenzodiazepines | |
GB1178982A (en) | Anthelmintic Compositions | |
GB1350114A (en) | Anabolic treatment of domestic animals | |
GB1088096A (en) | Benzimidazole, benzoxazole and benzothiazole derivatives | |
GB1362845A (en) | Benzyl alcohol derivatives | |
GB1290841A (en) | ||
GB1051823A (en) | ||
GB1333992A (en) | Method of and compositions for combating mareks disease | |
GB1283632A (en) | Phenylethanolamine derivatives | |
GB1260234A (en) | Veterinary methods and compositions | |
GB1272340A (en) | Derivatives of neriifolin | |
GB1169990A (en) | Phenoxy Propan-2-Olamines | |
IE35640B1 (en) | Diphenyl sulfones | |
GB1277529A (en) | Antiinflammatory compositions | |
GB1166793A (en) | Substituted Benzamides | |
GB1388041A (en) | Benzimidazolyl sulphides and sulphones | |
GB1299037A (en) | Dithiocarbamic acid esters | |
GB1314956A (en) | Chromone compounds | |
GB1303919A (en) | ||
GB1211307A (en) | Aminopropanediol derivatives and compositions containing them |